On September 3, 2024 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ("TIL") therapies for patients with cancer, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, SEP 3, 2024, View Source [SID1234646296]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Healthcare Conference
Fireside Chat: September 4, 2024 at 3:45 p.m. ET
Boston, MA
Baird Global Healthcare Conference
Fireside Chat: September 10, 2024 at 2:35 p.m. ET
New York, NY
H.C. Wainwright Global Investment Conference
Presentation: September 11, 2024 at 11:00 a.m. ET
New York, NY
The live and archived webcasts will be available at View Source